TRENDS IN THE USE OF SECOND-GENERATION ANDROGEN RECEPTOR AXIS INHIBITORS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER AND CLINICAL FACTORS PREDICTING BIOLOGICAL RECURRENCE

被引：0
|
作者：
Nakane, Keita
Watanabe, Hiromitsu
Naiki, Taku
Takahara, Kiyoshi
Yasui, Takahiro
Miyake, Hideaki
Shiroki, Ryoichi
Koie, Takuya
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP60-09
引用
收藏
页码：E1002 / E1003
页数：2
相关论文
共 50 条
  • [41] Comparative effectiveness of multiple androgen receptor signaling inhibitor medicines with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a study in the real world
    Lu, Yutong
    Jiang, Jingqi
    Yang, Gaoyang
    Ding, Hui
    Zheng, Qihui
    Ji, Luhua
    Wang, Yuhan
    Dong, Zhilong
    Zhai, Zhenxing
    Tian, Junqiang
    Zhang, Yunxing
    Wang, Juan
    Yang, Li
    Wang, Zhiping
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] Re: Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-Sensitive Prostate Cancer Receiving Androgen Deprivation Therapy
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2021, 206 (03): : 772 - 772
  • [43] Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer A Randomized Clinical Trial
    Vaishampayan, Ulka N.
    Heilbrun, Lance K.
    Monk, Paul, III
    Tejwani, Sheela
    Sonpavde, Guru
    Hwang, Clara
    Smith, Daryn
    Jasti, Pallavi
    Dobson, Kimberlee
    Dickow, Brenda
    Heath, Elisabeth I.
    Semaan, Louie
    Cher, Michael L.
    Fontana, Joseph A.
    Chinni, Sreenivasa
    JAMA NETWORK OPEN, 2021, 4 (01) : E2034633
  • [44] Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
    Kita, Yuki
    Goto, Takayuki
    Akamatsu, Shusuke
    Yamasaki, Toshinari
    Inoue, Takahiro
    Ogawa, Osamu
    Kobayashi, Takashi
    CANCERS, 2018, 10 (10)
  • [45] Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage
    Ibanez, Cristina
    Touris-Lores, Manuel
    Montesa, Alvaro
    Lopez-Campos, Fernando
    Rios, Emilio
    Usan, Paola
    Moretones, Cristina
    Conde-Estevez, David
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2025,
  • [46] Efficacy of novel androgen axis inhibitors for the treatment of hormone-sensitive prostate cancer in patients with visceral metastases: a systematic review and meta-analysis
    Murazov, Ia. G.
    Prokhorov, D. G.
    Tareev, Yu. S.
    Smirnov, R. V.
    ONKOUROLOGIYA, 2022, 18 (02): : 171 - 181
  • [47] Updates in the Treatment of Non-Metastatic Castrate-Resistant Prostate Cancer: The Benefit of Second-Generation Androgen Receptor Antagonists
    Hadfield, Matthew J. J.
    Lyall, Vikram
    Holle, Lisa M. M.
    Dennison, Morgan
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (11) : 1302 - 1311
  • [48] Comparative efficacy of second-generation androgen receptor inhibitors for treating prostate cancer: A systematic review and network meta-analysis
    Chen, Xiangyu
    Wang, Qihua
    Pan, Yang
    Wang, Shangren
    Li, Yuezheng
    Zhang, Hao
    Xu, Mingming
    Zhou, Hang
    Liu, Xiaoqiang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [49] Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors
    de Herreros, Marta Garcia
    Jimenez, Natalia
    Rodriguez-Carunchio, Leonardo
    Lillo, Eva
    Marin-Aguilera, Mercedes
    Ferrer-Mileo, Laura
    Aversa, Caterina
    Garcia-Esteve, Samuel
    Padrosa, Joan
    Trias, Isabel
    Fernandez-Manas, Laia
    Font, Albert
    Chirivella, Isabel
    Figols, Mariona
    Climent, Miguel Angel
    Prat, Aleix
    Reig, Oscar
    Mellado, Begona
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 70 : 86 - 90
  • [50] Estrogen receptor β and TMPRSS2-ERG expression association with clinical outcomes in metastatic hormone-sensitive prostate cancer.
    Aversa, Caterina
    Enez, Natalia Jim .
    Marin, Mercedes
    Ferrer-Mileo, Laura
    Reig, Oscar
    Rodriguez-Carunchio, Leonardo
    Font, Albert
    Rodriguez-Vida, Alejo
    Domenech-Santasusana, Montserrat
    Figols, Mariona
    Duran, Miguel Angel Climent
    Costa, Sara Cros
    Chirivella, Isabel
    Rivera, Daniel Herrero
    Gonzalez-Billalabeitia, Enrique
    Enez-Peralta, Daniel Jim
    Carles, Joan
    Suarez, Cristina
    Prat, Aleix
    Mellado, Begona
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345